| scholarly article | Q13442814 |
| P2093 | author name string | Christie M Bartels | |
| Ann M Chodara | |||
| Aimée Wattiaux | |||
| P2860 | cites work | Glucocorticoid dose thresholds associated with all-cause and cardiovascular mortality in rheumatoid arthritis | Q87248594 |
| Cardiovascular disease assessment in rheumatoid arthritis: a guide to translating knowledge of cardiovascular risk into clinical practice | Q87415483 | ||
| Gaps in Addressing Cardiovascular Risk in Rheumatoid Arthritis: Assessing Performance Using Cardiovascular Quality Indicators | Q88041807 | ||
| Training health professionals in smoking cessation | Q24197996 | ||
| Use of electronic health records to support smoking cessation | Q24234098 | ||
| Behavioral and Pharmacotherapy Interventions for Tobacco Smoking Cessation in Adults, Including Pregnant Women: U.S. Preventive Services Task Force Recommendation Statement | Q28267589 | ||
| Shared care or nursing consultations as an alternative to rheumatologist follow-up for rheumatoid arthritis outpatients with low disease activity—patient outcomes from a 2-year, randomised controlled trial | Q29030405 | ||
| Inflammation in atherosclerosis | Q29547428 | ||
| 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8) | Q29617334 | ||
| 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines | Q29620108 | ||
| Cardiovascular Disease Risk in Patients with Rheumatic Diseases | Q30240680 | ||
| The effect of smoking on response and drug survival in rheumatoid arthritis patients treated with their first anti-TNF drug | Q60777591 | ||
| Protocol-based treatment of hypertension: a critical step on the pathway to progress | Q64126588 | ||
| The association of hypertension with asymptomatic cardiovascular organ damage in rheumatoid arthritis. | Q64901257 | ||
| A retrospective cohort study of cigarette smoking and risk of rheumatoid arthritis in female health professionals | Q77738626 | ||
| Increased augmentation index in rheumatoid arthritis and its relationship to coronary artery atherosclerosis | Q80124180 | ||
| Prevalence and associations of hypertension and its control in patients with rheumatoid arthritis | Q80808131 | ||
| A clinical blueprint to accelerate the elimination of tobacco use | Q81226523 | ||
| Effects of disease modifying anti-rheumatic drugs on subclinical atherosclerosis and endothelial dysfunction which has been detected in early rheumatoid arthritis: 1-year follow-up study | Q86136689 | ||
| EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update | Q30244903 | ||
| EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis | Q33505914 | ||
| Abnormal function of high-density lipoprotein is associated with poor disease control and an altered protein cargo in rheumatoid arthritis | Q33687843 | ||
| Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritis | Q34547253 | ||
| Impact of rheumatoid arthritis on receiving a diagnosis of hypertension among patients with regular primary care | Q34724972 | ||
| Improved blood pressure control associated with a large-scale hypertension program | Q34730228 | ||
| Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force. Endorsed by the Society for V | Q34748094 | ||
| Low frequency of primary lipid screening among medicare patients with rheumatoid arthritis | Q34917991 | ||
| Tocilizumab in rheumatoid arthritis: a case study of safety evaluations of a large postmarketing data set from multiple data sources | Q35318027 | ||
| Disease activity in rheumatoid arthritis and the risk of cardiovascular events | Q35655764 | ||
| Current smoking status is a strong predictor of radiographic progression in early rheumatoid arthritis: results from the SWEFOT trial | Q35891851 | ||
| Proteomic profiling following immunoaffinity capture of high-density lipoprotein: association of acute-phase proteins and complement factors with proinflammatory high-density lipoprotein in rheumatoid arthritis | Q35899148 | ||
| The role of rheumatoid arthritis (RA) flare and cumulative burden of RA severity in the risk of cardiovascular disease | Q35904678 | ||
| Sustained Improvement of Arterial Stiffness and Blood Pressure after Long-Term Rosuvastatin Treatment in Patients with Inflammatory Joint Diseases: Results from the RORA-AS Study | Q35993667 | ||
| Usefulness of risk scores to estimate the risk of cardiovascular disease in patients with rheumatoid arthritis | Q36098818 | ||
| Lipid testing in patients with rheumatoid arthritis and key cardiovascular-related comorbidities: a medicare analysis | Q36113398 | ||
| Cholesterol efflux by high density lipoproteins is impaired in patients with active rheumatoid arthritis. | Q36190844 | ||
| Effects of Methotrexate on Carotid Intima-media Thickness in Patients with Rheumatoid Arthritis. | Q36241707 | ||
| Cardiovascular risk in rheumatoid arthritis: comparing TNF-α blockade with nonbiologic DMARDs | Q36361147 | ||
| Prevalence of traditional modifiable cardiovascular risk factors in patients with rheumatoid arthritis: comparison with control subjects from the multi-ethnic study of atherosclerosis | Q36511541 | ||
| Development of Cardiovascular Quality Indicators for Rheumatoid Arthritis: Results from an International Expert Panel Using a Novel Online Process | Q36593810 | ||
| Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2. | Q36738148 | ||
| Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA study | Q36757060 | ||
| Effects of Nicotine Patch vs Varenicline vs Combination Nicotine Replacement Therapy on Smoking Cessation at 26 Weeks: A Randomized Clinical Trial | Q36777034 | ||
| Hydroxychloroquine Use Is Associated With Decreased Incident Cardiovascular Events in Rheumatoid Arthritis Patients | Q36877859 | ||
| Changes in lipoproteins associated with methotrexate or combination therapy in early rheumatoid arthritis: results from the treatment of early rheumatoid arthritis trial. | Q36901936 | ||
| Suboptimal cardiovascular risk factor identification and management in patients with rheumatoid arthritis: a cohort analysis | Q36907729 | ||
| Rheumatologist and Primary Care Management of Cardiovascular Disease Risk in Rheumatoid Arthritis: Patient and Provider Perspectives. | Q36970912 | ||
| Coronary calcium predicts events better with absolute calcium scores than age-sex-race/ethnicity percentiles: MESA (Multi-Ethnic Study of Atherosclerosis). | Q37120370 | ||
| The impact of identifying carotid plaque on addressing cardiovascular risk in psoriatic arthritis | Q37144730 | ||
| Ask-Advise-Connect: a new approach to smoking treatment delivery in health care settings | Q37380453 | ||
| 2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult - 2009 recommendations | Q37435149 | ||
| Rationale and design of the Cardiovascular Inflammation Reduction Trial: a test of the inflammatory hypothesis of atherothrombosis | Q37466366 | ||
| Low-dose prednisolone treatment of early rheumatoid arthritis and late cardiovascular outcome and survival: 10-year follow-up of a 2-year randomised trial. | Q37704498 | ||
| Can suppression of inflammation by anti-TNF prevent progression of subclinical atherosclerosis in inflammatory arthritis? | Q38185646 | ||
| Do statins reduce the cardiovascular risk in patients with rheumatoid arthritis? | Q38220433 | ||
| Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force | Q38476881 | ||
| Survival after the onset of congestive heart failure in Framingham Heart Study subjects | Q38512499 | ||
| Physical activity in patients with rheumatoid arthritis | Q38660163 | ||
| Implementation of treat-to-target in rheumatoid arthritis through a Learning Collaborative: Rationale and design of the TRACTION trial | Q38802166 | ||
| Predictive Value of Arterial Stiffness and Subclinical Carotid Atherosclerosis for Cardiovascular Disease in Patients with Rheumatoid Arthritis | Q38852492 | ||
| Cardiovascular disease in inflammatory rheumatic diseases | Q39037783 | ||
| Prediction of cardiovascular risk in rheumatoid arthritis: performance of original and adapted SCORE algorithms. | Q39037812 | ||
| Long-term absolute benefit of lowering blood pressure in hypertensive patients according to the JNC VI risk stratification | Q39317741 | ||
| Incidence and Management of Cardiovascular Risk Factors in Psoriatic Arthritis and Rheumatoid Arthritis: A Population-Based Study | Q39328180 | ||
| Prevalence, extent and composition of coronary plaque in patients with rheumatoid arthritis without symptoms or prior diagnosis of coronary artery disease | Q39378053 | ||
| Traditional Cardiovascular Disease Risk Factor Management in Rheumatoid Arthritis Compared to Matched Nonrheumatoid Arthritis in a US Managed Care Setting | Q40492165 | ||
| Long-Term Outcomes of Patients With Recent-Onset Rheumatoid Arthritis After 10 Years of Tight Controlled Treatment: A Randomized Trial | Q40794551 | ||
| Early phase clinical and biological markers associated with subclinical atherosclerosis measured at 7 years of evolution in an early inflammatory arthritis cohort | Q40991763 | ||
| Derivation and internal validation of an expanded cardiovascular risk prediction score for rheumatoid arthritis: a Consortium of Rheumatology Researchers of North America Registry Study | Q41728784 | ||
| Improvement of High-Density Lipoprotein Function in Patients With Early Rheumatoid Arthritis Treated With Methotrexate Monotherapy or Combination Therapies in a Randomized Controlled Trial | Q41914520 | ||
| Preventive health services for systemic lupus erythematosus patients: whose job is it? | Q42663522 | ||
| Anti-TNF-alpha agents are less effective for the treatment of rheumatoid arthritis in current smokers | Q43201741 | ||
| Vital signs: awareness and treatment of uncontrolled hypertension among adults--United States, 2003-2010. | Q43464980 | ||
| Development of healthcare quality indicators for rheumatoid arthritis in Europe: the eumusc.net project | Q43493651 | ||
| Open-label tofacitinib and double-blind atorvastatin in rheumatoid arthritis patients: a randomised study | Q43686388 | ||
| COX-2 selective non-steroidal anti-inflammatory drugs and risk of serious coronary heart disease | Q44182620 | ||
| Patients with regular physical activity before onset of rheumatoid arthritis present with milder disease. | Q44929035 | ||
| Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study | Q44973310 | ||
| Clinical practice guidelines for the management of hypertension in the community a statement by the American Society of Hypertension and the International Society of Hypertension | Q44990922 | ||
| Statin discontinuation and risk of acute myocardial infarction in patients with rheumatoid arthritis: a population-based cohort study | Q45205227 | ||
| Ambulatory medical care utilization estimates for 2007. | Q45293414 | ||
| Smoking cessation advice by rheumatologists: results of an international survey | Q45393589 | ||
| The risk of myocardial infarction in rheumatoid arthritis and diabetes mellitus: a Danish nationwide cohort study | Q45792532 | ||
| Risk of incident cardiovascular events in patients with rheumatoid arthritis: a meta-analysis of observational studies. | Q46003173 | ||
| Impact of statin discontinuation on mortality in patients with rheumatoid arthritis: a population-based study | Q46370506 | ||
| Increased arterial stiffness and indication of endothelial dysfunction in long-standing rheumatoid arthritis | Q46812634 | ||
| Cost-Effectiveness of Cardiovascular Screening in Patients With Rheumatoid Arthritis | Q47802987 | ||
| Results from systematic screening for cardiovascular risk in outpatients with rheumatoid arthritis in accordance with the EULAR recommendations | Q48008568 | ||
| Shared care or nurse consultations as an alternative to rheumatologist follow-up for rheumatoid arthritis (RA) outpatients with stable low disease-activity RA: cost-effectiveness based on a 2-year randomized trial | Q48060466 | ||
| Performance of four current risk algorithms in predicting cardiovascular events in patients with early rheumatoid arthritis. | Q51126183 | ||
| Results of a specific smoking cessation program for patients with arthritis in a rheumatology clinic. | Q51224150 | ||
| A treat-to-target strategy with methotrexate and intra-articular triamcinolone with or without adalimumab effectively reduces MRI synovitis, osteitis and tenosynovitis and halts structural damage progression in early rheumatoid arthritis: results fr | Q51759356 | ||
| Differences in atherosclerotic coronary heart disease between subjects with and without rheumatoid arthritis. | Q51761535 | ||
| Glucocorticoid use is associated with increase in HDL and no change in other lipids in rheumatoid arthritis patients. | Q53653844 | ||
| Patients with early rheumatoid arthritis who smoke are less likely to respond to treatment with methotrexate and tumor necrosis factor inhibitors: Observations from the Epidemiological Investigation of Rheumatoid Arthritis and the Swedish Rheumatolog | Q57224416 | ||
| Predictors of response to anti-TNF- therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register | Q57751361 | ||
| Effects of high-intensity resistance training in patients with rheumatoid arthritis: A randomized controlled trial | Q57915748 | ||
| Immediate and past cumulative effects of oral glucocorticoids on the risk of acute myocardial infarction in rheumatoid arthritis: a population-based study | Q58160099 | ||
| Individualised aerobic and resistance exercise training improves cardiorespiratory fitness and reduces cardiovascular risk in patients with rheumatoid arthritis | Q59394199 | ||
| P433 | issue | 4 | |
| P921 | main subject | rheumatoid arthritis | Q187255 |
| cardiovascular disease | Q389735 | ||
| P304 | page(s) | 16 | |
| P577 | publication date | 2017-04-01 | |
| P1433 | published in | Current Rheumatology Reports | Q23930052 |
| P1476 | title | Managing Cardiovascular Disease Risk in Rheumatoid Arthritis: Clinical Updates and Three Strategic Approaches | |
| P478 | volume | 19 |
| Q61445239 | Awareness and perceived risk of cardiovascular disease among individuals living with rheumatoid arthritis is low: results of a systematic literature review |
| Q64092332 | Cardiac and vascular complications in rheumatoid arthritis |
| Q49684530 | Identification of potential genetic causal variants for rheumatoid arthritis by whole-exome sequencing |
| Q45804014 | The Role of High-Mobility Group Box-1 and Its Crosstalk with Microbiome in Rheumatoid Arthritis. |
Search more.